Clinical Trial Update: Tezepelumab COPD Exacerbation Study [Phase 2]

View source ↗

Summary

Phase 2 trial of tezepelumab for COPD exacerbations has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED | Results posted: 2025-02-18